Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Novo Nordisk to cut US list prices of Ozempic, Wegovy

Digest more
Top News
Overview
 · 3h
Novo to cut Ozempic and Wegovy prices amid intense competition
Novo Nordisk said it will slash list prices of the blockbuster diabetes and weight-loss medications Ozempic, Rybelsus, and Wegovy to $675 for a one-month supply effective Jan. 1, 2027.

Continue reading

 · 2h
Novo Nordisk announces plan to cut Ozempic and Wegovy prices up to 50 percent
 · 1h
Ozempic, Wegovy prices to drop up to 50% as Novo Nordisk’s rivalry with Eli Lilly heats up: report
 · 7h
Novo Nordisk to halve US list price of Wegovy from 2027
Feb 24 (Reuters) - Novo Nordisk (NOVOb.CO) will slash U.S. list prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 50% starting next year to $675 a month, the Danish ...

Continue reading

 · 8h
Novo Nordisk to Cut U.S. List Prices for Ozempic, Wegovy by Up to 50%
Axios · 7h
Novo Nordisk cuts sticker price of weight-loss drugs
2hon MSN

Popular weight-loss drugs getting cheaper amid price war

Novo Nordisk announced plans to drastically reduce the list price of its versions, Wegovy, Ozempic and Rybelsus.
2don MSN

GLP-1 wars: Wegovy maker challenges knock-off weight loss drug companies

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss drugs.
21hon MSN

FDA cracks down on weight-loss drug alternatives as thousands sickened in Maryland

Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy labs, sickened some 8,000 or more Marylanders a year by 2024. The Food and Drug Administration announced this month that it will crack down on compounded versions of GLP-1 drugs,
1d

Eli Lilly launches new weight-loss drug Zepbound KwikPen: What to know

Eli Lilly announced on " Good Morning America " Monday that its GLP-1 weight-loss drug Zepbound will now be available in a new multi-dose KwikPen, giving patients a simpler way to receive a full month of treatment in one device.
  • Privacy
  • Terms